Early results from Moderna coronavirus vaccine trial show participants developed antibodies against the virus
May 18 , 2020

By Elizabeth Cohen, CNN HEALTH

https://www.cnn.com/2020/05/18/health/coronavirus-vaccine-moderna-early-results/index.html

Volunteers who received Moderna's Covid-19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes of Health to develop the vaccine.

If future studies go well, the company's vaccine could be available to the public as early as January, Dr. Tal Zaks, Moderna's chief medical officer, told CNN.

"This is absolutely good news and news that we think many have been waiting for for quite some time," Zaks said.

These early data come from the Phase 1 clinical trial, which typically studies a small number of people and focuses on whether a vaccine is safe and elicits an immune response. 

The results of the study, which was led by the National Institutes of Health, have not been peer reviewed or published in a medical journal.

お問い合わせはこちらからお願いします。 お問い合わせ